Utah Medical Products, Inc. (UTMD)
69.16
-1.94
(-2.73%)
USD |
NASDAQ |
Sep 08, 16:00
67.99
-1.17
(-1.69%)
After-Hours: 20:00
Utah Medical Products Debt to Equity Ratio : 0.0016 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0016 |
| March 31, 2026 | 0.0017 |
| December 31, 2025 | 0.0024 |
| September 30, 2025 | 0.002 |
| June 30, 2025 | 0.0022 |
| March 31, 2025 | 0.0023 |
| December 31, 2024 | 0.0029 |
| September 30, 2024 | 0.0024 |
| June 30, 2024 | 0.0022 |
| March 31, 2024 | 0.0022 |
| December 31, 2023 | 0.0027 |
| September 30, 2023 | 0.0025 |
| June 30, 2023 | 0.0026 |
| March 31, 2023 | 0.0028 |
| December 31, 2022 | 0.0035 |
| September 30, 2022 | 0.0033 |
| June 30, 2022 | 0.0034 |
| March 31, 2022 | 0.0035 |
| December 31, 2021 | 0.0042 |
| September 30, 2021 | 0.0031 |
| June 30, 2021 | 0.0033 |
| March 31, 2021 | 0.0035 |
| December 31, 2020 | 0.0037 |
| September 30, 2020 | 0.0039 |
| June 30, 2020 | 0.0041 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0039 |
| December 31, 2019 | 0.0041 |
| September 30, 2019 | 0.0044 |
| June 30, 2019 | 0.0046 |
| March 31, 2019 | 0.0048 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.0754 |
| September 30, 2014 | 0.0933 |
| June 30, 2014 | 0.1114 |
| March 31, 2014 | 0.1293 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
| Baxter International, Inc. | 1.427 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 124.57M |
| Total Liabilities (Quarterly) | 2.539M |
| Shareholders Equity (Quarterly) | 122.03M |
| Current Ratio | 48.62 |
| Net Debt Paydown Yield | 0.01% |